Treatment of HCV-related liver diseases after renal transplantation: modern views.
Fabrizi
F
F
Division of Nephrology, Maggiore Hospital, IRCCS, Milano, Italy. fabrizi@policlinico.mi.it
Bunnapradist
S
S
Aucella
F
F
Lunghi
G
G
Martin
P
P
D000998:Antiviral Agents / Q000627:therapeutic use*; D006085:Graft Survival; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects; D011994:Recombinant Proteins; D006435:Renal Dialysis; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin